ImmunoPrecise Antibodies Ltd. (HYFT) — Capital Reinvestment Ratio
ImmunoPrecise Antibodies Ltd. (HYFT) has a Capital Reinvestment Ratio of 1.62x as of October 2020, meaning it reinvests 2% of its operating cash flow ($440.23K) in capital expenditures ($715.21K). See HYFT net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ImmunoPrecise Antibodies Ltd. Capital Reinvestment Ratio (2016–2016)
This chart tracks ImmunoPrecise Antibodies Ltd.'s Capital Reinvestment Ratio across 1 annual periods. Check cash flow reinvestment rate of ImmunoPrecise Antibodies Ltd. to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for ImmunoPrecise Antibodies Ltd. (2016–2016)
Year-by-year Capital Reinvestment Ratio for ImmunoPrecise Antibodies Ltd. from 2016 to 2016. For live market cap and broader valuation context, see HYFT company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.06x | $284.09K | $17.48K | — |